Abstract: The present disclosure provides a novel palatable pharmaceutical composition in the form of taste-masked 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and orally disintegrating tablets comprising the same. The taste-masked orally disintegrating tablets of this invention will significantly reduce the potently bitter taste of lasmiditan, and enable administration of this product form to migraine patients, in particular pediatric patients and those suffering from nausea due to migraine attacks.